Results 151 to 160 of about 534,463 (213)

MHC1-TIP enables single-tube multimodal immunopeptidome profiling and uncovers intratumoral heterogeneity in antigen presentation. [PDF]

Commun Biol
Bathini M, Bocaniciu D, Johnson FD, de Jong RCP, Yu F, Aloi VD, Kuiken MC, Mors JR, Giebel L, Champagne J, Bleijerveld O, Agami R, Dijkstra KK, Thommen DS, Nesvizhskii AI, Lindeboom RGH.   +15 more
europepmc   +1 more source

Retraction for Atractylenolide I enhances responsiveness to immune checkpoint blockade therapy by activating tumor antigen presentation. [PDF]

J Clin Invest
Xu H, Van der Jeught K, Zhou Z, Zhang L, Yu T, Sun Y, Li Y, Wan C, So KM, Liu D, Frieden M, Fang Y, Mosley AL, He X, Zhang X, Sandusky GE, Liu Y, Meroueh SO, Zhang C, Wijeratne AB, Huang C, Ji G, Lu X.   +22 more
europepmc   +1 more source

Lymphodepleting chemotherapy potentiates neoantigen-directed T cell therapy by enhancing antigen presentation. [PDF]

Cell Rep Med
Sagie S, Babu T, Weller C, Tabachnik C, Livneh I, Quast NP, Gumpert N, Shomuradova A, Raybould MI, Levy R, Malko D, Alfia A, Ben Lulu T, Alon M, Herrera F, Kutuzov M, Zerbib M, Greenberg P, Wasserman-Bartov T, Benedek G, Levin Y, Stossel C, Kamer I, Golan T, Oren R, Shmueli M, Bartok O, Bar J, Cohen J, Dushek O, Deane CM, Samuels Y.   +31 more
europepmc   +1 more source

HLA-DRB1 Allelic Combinations Differentially Shape Dendritic Cell Antigen Presentation Enhanced by Tumour Cell Line Lysate-Pulsing. [PDF]

HLA
Lázaro G, Cedano JA, Faus M, Roura-Mir C, Garrigós L, Pérez-García J, Román-García J, Cortés J, Aran A, Martí M.   +9 more
europepmc   +1 more source

Lactate-induced metabolic reprogramming of TAMs impairs antigen presentation capacity via C/EBPα-CD74 axis in oral squamous cell carcinoma. [PDF]

Clin Transl Med
Wang M, Wang M, Gong Z, Zeng F, Ni Z, Zhai R, Zhu W, Zhang J, Liu L.   +8 more
europepmc   +1 more source

Islet amyloid disrupts MHC class II antigen presentation and delays autoimmune diabetes in NOD mice. [PDF]

Diabetologia
Denroche HC, Ng V, Velghe J, Suen I, Stanley L, Nackiewicz D, Komba M, Dai DL, Soukhatcheva G, Chen S, Verchere CB.   +10 more
europepmc   +1 more source

Cmss1 limits FMDV infection by enhancing antigen presentation and CD8⁺ T cell responses. [PDF]

J Virol
Wang Y, Zhang L, Deng J, Zheng L, Chen Z, Zhang Z, Zhang H, Pei J, Zheng H.   +8 more
europepmc   +1 more source

<i>Brucella</i> Immune Escape: TLR Subversion, Antigen Presentation Destruction and T Cell Disorder. [PDF]

Cells
Jiao H, Zhou G, Wu S, Meng C, Wang L, Fan C, Li J, Chu Y.   +7 more
europepmc   +1 more source

CD73 blockade enhances antitumor efficacy of oHSV in solid tumors by increasing macrophage-mediated antigen presentation. [PDF]

J Immunother Cancer
Murphy SA, Li J, Sahu U, Swanner J, Lewis CT, Anchang B, Cui Y, Chiocca EA, Kaur B.   +8 more
europepmc   +1 more source